Skip to main content
Loading

YDS Pharmatech, Inc.

October 17, 2023
Franciscan C
Oncology
Company Description: YDS Pharmatech, Inc. is heading for next-generation induced-proximity drug discovery. Using our AI+biophysics simulation combined with proteomics technologies to advance the discovery of new E3 ligase and neosubstrates.
Speakers
Xing Che, CEO - YDS Pharmatech, Inc.

Country

United States

Website

http://www.yds-pharmatech.com

CEO/Top Company Official

Xing Che

Lead Product in Development

GSPT1 degrader

Development Phase of Primary Product

Pre-Clinical

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS